Close

More on TVTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-52.6% Growth)
- Ratings (6.2 Score)

Upcoming Events

- Earnings (2/27/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Travere Therapeutics (NQ:TVTX)
Delayed: 8.65 --0 (-0%)
Prev. Close $8.65  
Open$8.65 
52 Wk High$ 
52 Wk Low$ 
Day High$8.65 
Day Low$8.65 
P/E N/A  
EPS$ 
Volume5 

Friends, Peers and Foes (?): LGND, MIRM, VKTX, JAZZ, VRNA (more...)

Dec 5, 2023 09:18 AM Evercore ISI on Travere Therapeutics (TVTX): 'We think the stock remains undervalued'
Dec 5, 2023 06:54 AM Citi Upgrades Travere Therapeutics (TVTX) to Buy
Dec 4, 2023 04:11 PM Form 8-K Travere Therapeutics, For: Nov 30
Dec 4, 2023 04:06 PM Travere Therapeutics (TVTX) Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS
Dec 4, 2023 04:05 PM Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS
Nov 21, 2023 04:30 PM Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
Nov 20, 2023 05:09 AM Citi Starts Travere Therapeutics (TVTX) at Neutral
Nov 8, 2023 04:01 PM Ligand Reports Third Quarter 2023 Financial Results
Nov 8, 2023 06:23 AM Travere Therapeutics (TVTX) PT Lowered to $11 at Evercore ISI
Nov 7, 2023 05:15 PM Form 10-Q Travere Therapeutics, For: Sep 30
View All Articles

Entities mentioned with TVTX

View All Entities